✦ LIBER ✦

Weekly docetaxel as second line chemotherapy in advanced non small cell lung cancer (NSCLC): Final results and survival analysis

✍ Scribed by M. Serke; D. Argiropolus; N. Schönfeld; R. Loddenkemper

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second line weekly docetaxel in advanced

✍ Serke, M; Rücker, M; Schönfeld, N; Loddenkemper, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Weekly docetaxel as second line chemothe

✍ Emilio Bria; Federica Cuppone; Mariangela Ciccarese; Cecilia Nisticò; Francesco 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Weekly docetaxel vs. docetaxel-based com

✍ Gebbia, Vittorio; Gridelli, Cesare; Verusio, Claudio; Frontini, Luciano; Aitini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Weekly docetaxel as first-line therapy f

✍ Hainsworth, J.D; Burris, H.A; Morrissey, L.H; Litchy, S; Greco, F.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB

P-500 Weekly docetaxel and vinorelbine a

✍ Huber, R.; Schmidt, M.; Borgmeier, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB